Drug Patent Expirations for the week of February 9, 2014

Drug Patent Expirations for the week of February 9, 2014

Tradename	Applicant	Generic Name	Patent No.
EXELON	Novartis	rivastigmine tartrate	5,602,176
TEMODAR	Merck Sharp Dohme	temozolomide	5,260,291*PED
ARTHROTEC	Gd Searle Llc	diclofenac sodium; misoprostol	5,601,843
TRITEC	Glaxosmithkline	ranitidine bismuth citrate	5,601,848
HECTOROL	Genzyme Corp	doxercalciferol	5,602,116
EXELON	Novartis	rivastigmine	5,602,176
NIASPAN	Abbvie	niacin	6,818,229
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.